A meta-analysis confirmed a strong positive association between BMI and circulating SAA levels (13), and showed that SAA1 and SAA2 expression was higher in subcutaneous WAT in people with overweight and/or obesity (97, 106). The gene discussed is SAA2; the disease is obesity due to melanocortin 4 receptor deficiency.